The Christ Hospital Heart & Vascular Institute Heart Failure Symposium 2025

Description

+ Include: 12 Videos (.mp4) + 12 Audios (.mp3) + 12 Subtitles (.vtt) + 13 PDFs, size: 4.31 GB

+ Target Audience: heart failure specialists and cardiologists

+ Sample video: contact me for sample video

+ Information:

1. Overview

The Christ Hospital Heart & Vascular Institute Heart Failure Symposium 2025 delivers a cutting-edge review of advanced heart failure management, ranging from foundational medical therapies to the latest in mechanical circulatory support. The course highlights emerging device technologies, updates in heart transplantation, and novel pharmacological treatments for specific cardiomyopathies like amyloidosis and hypertrophic cardiomyopathy.

Course Date: 2025

2. Learning Objectives

• Optimize foundational medical therapies to establish the most effective base for heart failure care.

• Evaluate emerging research innovations and devices, including Doraya, Precardia, and WhiteSwell.

• Discuss the latest 2025 updates in heart transplantation and advancements in LVAD pump design.

• Apply new therapeutic strategies for amyloidosis and hypertrophic cardiomyopathy, including myosin inhibitors.

• Manage acute failure with short-term support (ECMO, Impella) and explore the future of total artificial hearts (BIVACOR).

3. Target Audience

Best for heart failure specialists and cardiologists who want updates on transplant, MCS, amyloidosis, and emerging device therapies.

4. Topics

1. Medical Therapies- Forming the Most Effective Base

2. Research Innovations – Doraya, Precardia, WhiteSwell, Vectorius, CVRx

3. LVAD’s – Innovations in Management and Pump Design

4. Heart Transplantation – What’s New in 2025

5. Transcatheter Mitral and Tricuspid Devices – When to Intervene and How

6. Atrial Fibrillation and Heart Failure – General Approach in a Sick Population

7. Amyloidosis – The March of Cool Drugs

8. Hypertrophic Cardiomyopathy – Myosin Inhibitors and Beyond

9. Regenerative Therapies for Heart Failure – Successes and Challenges

10. ECMO – Indications, Exclusions, Management

11. Short-term Support – Impella, RVAD, IABP

12. Future of the Machines – BIVACOR